Styrylpyridinium Derivatives as New Potent Antifungal Drugs and Fluorescence Probes

0532982 - FGÚ 2021 RIV CH eng J - Článek v odborném periodiku
Vaitkiene, S. - Daugelavičius, R. - Sychrová, Hana - Kodedová, Marie
Styrylpyridinium Derivatives as New Potent Antifungal Drugs and Fluorescence Probes.
Frontiers in Microbiology. Roč. 11, Aug 28 (2020), č. článku 2077. ISSN 1664-302X. E-ISSN 1664-302X
Grant CEP: GA MŠMT(CZ) LM2015062; GA MŠMT(CZ) EF16_013/0001775; GA MŠMT(CZ) LQ1604; GA MŠMT(CZ) ED1.1.00/02.0109
Institucionální podpora: RVO:67985823
Klíčová slova: styrylpyridinium derivates * Candida glabrata * diS-C3(3)assay * membrane potential * yeast * multidrug resistence * vacuolar marker
Obor OECD: Microbiology
Impakt faktor: 5.640, rok: 2020
Způsob publikování: Open access
https://www.frontiersin.org/articles/10.3389/fmicb.2020.02077/full

The incidence ofCandida glabratainfections increases every year due to its higher resistance to commonly used antifungal drugs. We characterized the antifungal mechanism of action of eight new styrylpyridinium derivatives, with various N-alkyl chains (-C6H13, -C8H17, -C10H21, -C12H25) and different substituents, onC. glabratastrains differing in their drug resistance due to the presence or absence of two major drug-efflux pumps. We found that the tested styrylpyridinium compounds affected the growth ofC. glabratacells in a compound- and strain-dependent manner, and apparently they were substrates ofCgCdr1 andCgCdr2 pumps. Further, we determined the impact of the tested compounds on plasma membrane integrity. The ability to cause damage to a plasma membrane depended on the compound, its concentration and the presence of efflux pumps, and corresponded well with the results of growth and survival tests. We also tested possible synergism with three types of known antifungal drugs. Though we did not observe any synergism with azole drugs, styrylpyridinium compounds5and6together with FK506 demonstrated excellent antifungal properties, whereas compounds2,3,5, and6exhibited a significant synergistic effect in combination with terbinafine. Based on our results, derivatives2and6turned out to be the most promising antifungal drugs. Moreover, compound6was not only able to effectively permeabilize the yeast plasma membrane, but also exhibited significant synergism with FK506 and terbinafine. Finally, we also characterized the spectroscopic properties of the tested styrylpyridinium compounds. We measured their absorption and fluorescence spectra, determined their localization in yeast cells and found that their fluorescence characteristics differ from the properties of current commercial vacuolar styrylpyridinium markers and allow multi-color staining. Compounds1,3,7, and8were able to accumulate in plasma and vacuolar membranes, and compounds2,5, and6stained the whole interior of dead cells. In summary, of the eight tested compounds, compound6is the most promising antifungal drug, compound8, due to its minimal toxicity, is the best candidate for a new vacuolar-membrane probe or new benchmark substrate ofC. glabrataCdr pumps, and derivative5for a new vital dye.
Trvalý link: http://hdl.handle.net/11104/0311486